
The Quezon City Government and Boehringer Ingelheim Philippines have formally partnered to strengthen the fight against chronic kidney disease (CKD), launching a citywide initiative aimed at helping residents detect kidney problems early—before they lead to life-altering complications.
Through the signing of the Terms of Reference (TOR) for the “Iwas Dialysis, Ligtas Kidneys: Get CheCKD Habang Maaga Pa!” program, the partnership seeks to expand early CKD detection, boost kidney health awareness, and improve access to preventive care for QCitizens, particularly those most vulnerable to the disease.
The initiative will tap barangay health centers as frontliners in the campaign, supporting community-based screening efforts, promoting kidney health education, facilitating hospital referrals for residents with abnormal findings, and encouraging healthier lifestyle habits that can lower long-term risks.
The effort comes as chronic kidney disease continues to quietly emerge as a major public health concern in the Philippines. Around 13 million Filipinos—equivalent to 11.2 percent of the population—are estimated to be living with CKD, with many cases remaining undiagnosed until the disease has already reached advanced stages.
Boehringer Ingelheim said the program aligns with its global Sustainable Development for Generations (SD4G) commitment, which focuses on advancing healthcare equity and improving access to early intervention in underserved communities.
“Our SD4G commitment guides us to work alongside communities where access to early healthcare interventions can create meaningful impact,” said Dr. Bin Wang, General Manager of Boehringer Ingelheim (Philippines), Inc.
“By strengthening awareness and supporting early screening efforts, we hope to help more QCitizens better understand their kidney health and seek care before complications arise,” Wang added.
Medical experts stressed that CKD often develops silently, with symptoms such as fatigue, nausea, or skin irritation frequently overlooked until the condition has progressed significantly.
“Many patients only receive a diagnosis when the disease has already significantly progressed,” said Dr. Greta Cortez, Head of Medicine at Boehringer Ingelheim (Philippines), Inc.
She emphasized that individuals living with diabetes or hypertension face a higher risk of developing CKD, making early screening critical to preventing severe complications.
“Timely detection allows earlier intervention and can help reduce the risk of progression to advanced kidney disease,” Cortez said.
The Quezon City Health Department underscored that preventive healthcare and grassroots screening efforts remain key to protecting communities from chronic illnesses.
“Protecting QCitizens from chronic kidney disease starts with helping communities recognize the importance of early screening and prevention,” said Dr. Ramona Abarquez, Quezon City Health Officer.
“Through this initiative, we hope to encourage more residents, especially those at higher risk, to monitor their kidney health early and help prevent complications before they become life-threatening,” she added.
The rollout of the kidney health campaign reinforces Quezon City’s broader push toward preventive healthcare and accessible community wellness programs, helping residents take proactive steps toward protecting their long-term health.
QC residents are encouraged to participate in upcoming kidney screening and educational activities in their barangays as part of the city’s continuing effort to build healthier communities—one early diagnosis at a time.